In humans, IL-36α expression in the liver of hepatocellular carcinoma patients was found to be negatively correlated with tumor size and vascularization, while IL-36α expression was positively correlated with CD8+ tumor-infiltrating lymphocytes and patient survival (109). Here, IL36A is linked to neoplasm.